Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects

Inclusion Criteria: * Considered generally healthy upon completion of medical history, physical examination, vital signs and electrocardiogram (ECG), as judged by the Investigator (the Physician) * Body Mass Index (BMI): 19.0-24.0 kg/m2 (both inclusive) Exclusion Criteria: * Clinically significant abnormal haematology, biochemistry, lipids or urinalysis screening tests, as judged by the Investigator (the Physician) * A history of any illness that, in the opinion of the Investigator (the Physician), might confound the results of the trial or a pose risk in administering the trial product to the subject * Subject who has donated any blood or plasma in the past month or more than 400 mL within 3 months prior to screening (trial entry) * Not able or willing to refrain from smoking during the inpatient period